Advertisement

Treatment Guidelines

  • Kostas N. Fountoulakis
Chapter

Abstract

Treatment guidelines constitute one of the important developments in the field of psychiatry, after the introduction of the operationalized diagnostic criteria in the frame of modern classification systems and the advancing of evidence-based medicine (EBM) also in psychiatry. They emerged as an important element in order to summarize and clarify the research data and, to the extent this is possible, to standardize treatment on the basis of evidence. They also emerged as a response to the need of many clinicians for algorithms, which would be able to carry research findings to the everyday clinical practice by organizing information from diverse sources into an easily accessible and reliable format.

Keywords

Atypical Antipsychotic Mood Stabilizer Bipolar Depression Acute Mania Predominant Polarity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. AACAP (1997) AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 36(1):138–157CrossRefGoogle Scholar
  2. Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP (2001) The expert consensus guideline series. Treatment of behavioral emergencies. Postgrad Med (Spec no):1–88; quiz 89–90Google Scholar
  3. APA (1994) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151(12 Suppl):1–36Google Scholar
  4. APA (1995) American Psychiatric Association releases treatment guideline for bipolar disease. Am Fam Physician 51(6):1605–1606Google Scholar
  5. APA (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159(4 Suppl):1–50Google Scholar
  6. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder (2004) Aust N Z J Psychiatry 38(5):280–305. doi: 10.1111/j.1440-1614.2004.01356.x, ANP1356 [pii]
  7. Barreira P, Duckworth K, Goff D, Flannery RB Jr (1999) Clinical practice guidelines: the Massachusetts experience in psychiatry. Harv Rev Psychiatry 7(4):230–232PubMedCrossRefGoogle Scholar
  8. Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, Wittlin B, Powell BJ (1999) Clinical practice guidelines for bipolar disorder from the department of veterans affairs. J Clin Psychiatry 60(1):9–21PubMedCrossRefGoogle Scholar
  9. Beaulieu S, Saury S, Sareen J, Tremblay J, Schutz CG, McIntyre RS, Schaffer A, Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry 24(1):38–55PubMedGoogle Scholar
  10. Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, Weiss M, Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry 24(1):23–37PubMedGoogle Scholar
  11. Chou J, Zito J, Vitrai J, Craig T, Allingham B, Czobor P (1996) Neuroleptics in acute mania: a pharmacoepidemiologic study. Ann Pharmacother 30:1396–1398PubMedGoogle Scholar
  12. Cookson J (2001) Use of antipsychotic drugs and lithium in mania. Br J Psychiatry Suppl 41:s148–s156PubMedCrossRefGoogle Scholar
  13. Dennehy EB (2000) Guidelines for treatment of bipolar disorder. Curr Psychiatry Rep 2(4):316–321PubMedCrossRefGoogle Scholar
  14. Expert consensus guidelines are released for the treatment of bipolar disorder. Consensus Development Conferences (1997) Am Fam Physician 55(4):1447–1449Google Scholar
  15. Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, Moller HJ, Vieta E (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur Arch Psychiatry Clin Neurosci 262(Suppl 1):1–48. doi: 10.1007/s00406-012-0323-x PubMedCrossRefGoogle Scholar
  16. Fountoulakis KN, Vieta E (2008) Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharm 11(7):999–1029. doi: 10.1017/S1461145708009231 CrossRefGoogle Scholar
  17. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS (2005) Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 86(1):1–10. doi: 10.1016/j.jad.2005.01.004 PubMedCrossRefGoogle Scholar
  18. Frances A, Docherty J, Kahn D (1996) The expert consensus guideline series: treatment of bipolar disorder. J Clin Psychiatry 57(Suppl 12A):1–88Google Scholar
  19. Frangou S, Raymont V, Bettany D (2002) The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder. Bipolar Disord 4(6):378–385PubMedCrossRefGoogle Scholar
  20. Gilbert DA, Altshuler KZ, Rago WV, Shon SP, Crismon ML, Toprac MG, Rush AJ (1998) Texas medication algorithm project: definitions, rationale, and methods to develop medication algorithms. J Clin Psychiatry 59(7):345–351PubMedCrossRefGoogle Scholar
  21. Goldberg JF (2000) Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry 61(Supp 13):12–18PubMedGoogle Scholar
  22. Goodwin G, Bourgeois M, Conti L (1997) Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatry Clin Pract 1:S9–S12PubMedCrossRefGoogle Scholar
  23. Goodwin GM (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17(2):149–173; discussion 147PubMedCrossRefGoogle Scholar
  24. Goodwin GM (2009) Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol 23(4):346–388. doi: 10.1177/0269881109102919, 0269881109102919 [pii]PubMedCrossRefGoogle Scholar
  25. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, Vieta E, Moller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J Biol Psychiatry 3(3):115–124PubMedCrossRefGoogle Scholar
  26. Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, Vieta E, Moller HJ (2003) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J Biol Psychiatry 4(1):5–13PubMedCrossRefGoogle Scholar
  27. Grunze H, Kasper S, Goodwin G, Bowden C, Moller H (2004) WFSBP task force on treatment guidelines for bipolar disorders: the World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry 5(3):120–135PubMedCrossRefGoogle Scholar
  28. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S (2009) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 10(2):85–116. doi: 10.1080/15622970902823202, 910249156 [pii]PubMedCrossRefGoogle Scholar
  29. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S, Disorders WTFOTGFB (2010) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11(2):81–109. doi: 10.3109/15622970903555881 PubMedCrossRefGoogle Scholar
  30. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S, Disorders WTFoTGfB (2013) The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 14(3):154–219. doi: 10.3109/15622975.2013.770551 PubMedCrossRefGoogle Scholar
  31. Hirschfeld R (2005) Guideline watch for the practice guideline for the treatment of patients with bipolar disorder. http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm
  32. International consensus group on depression prevention in bipolar disorder (2011) J Clin Psychiatry 72(10):1295–1310. doi: 10.4088/JCP.10123co1c
  33. International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression (2008) J Clin Psychiatry 69(10):1632–1646, eaz7127 [pii]Google Scholar
  34. Jobson K (1997) International psychopharmacology algorithm project: algorithms in psychopharmacology. Int J Psychiatry Clin Pract 1:S3–S8PubMedCrossRefGoogle Scholar
  35. Jon DI, Bahk WM, Yoon BH, Shin YC, Cho HS, Lee E, Ha K, Kim W, Chung SK, Seo JS, Min KJ (2009) Revised Korean medication algorithm for bipolar disorder. World J Biol Psychiatry 10(4 Pt 3):846–855. doi: 10.1080/15622970802144865, 794876687 [pii]PubMedCrossRefGoogle Scholar
  36. Kusumakar V, Yatham L, Parikh S (1997) Bipolar disorder: a summary of clinical issues and treatment options. CANMAT Monograph, Halifax/Nova ScotiaGoogle Scholar
  37. Levine J, Chengappa KN, Brar JS, Gershon S, Yablonsky E, Stapf D, Kupfer DJ (2000) Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord 2(2):120–130PubMedCrossRefGoogle Scholar
  38. Licht R, Gouliaev G, Vestergaard P, Dybbro J, Lund H, Merinder L (1994) Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affect Disord 32:179–185PubMedCrossRefGoogle Scholar
  39. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH (2003) Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand 108(Suppl 419):1–22CrossRefGoogle Scholar
  40. Lim PZ, Tunis SL, Edell WS, Jensik SE, Tohen M (2001) Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines. Bipolar Disord 3(4):165–173PubMedCrossRefGoogle Scholar
  41. McClellan J, Werry J (1997) Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36(10 Suppl):157S–176SPubMedGoogle Scholar
  42. McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, Kemp DE, Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry 24(1):69–81PubMedGoogle Scholar
  43. Montgomery DB (2001) ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol 11(1):79–88PubMedCrossRefGoogle Scholar
  44. NCCfMH (2006) Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. CG38 NICE guideline. http://www.kenniscentrumbipolairestoornissen.nl/wp-content/uploads/NHS-guideline-bipolar-disorder.pdf
  45. Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M (2009) The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord 11(6):559–595. doi: 10.1111/j.1399-5618.2009.00737.x, BDI737 [pii]PubMedCrossRefGoogle Scholar
  46. Nolen W, Kupka R, Schulte P, Knoppert-van der Klein E, Honig A, Reichart C (2008) Richtlijn bipolaire stoornissen, 2nd edn. De Tijdstrom Uitgerverij BV, UtrechtGoogle Scholar
  47. O’Dowd A (2006) NICE issues new guidance to improve the treatment of bipolar disorder. BMJ 333(7561):220PubMedCentralPubMedCrossRefGoogle Scholar
  48. Rosenbluth M, Macqueen G, McIntyre RS, Beaulieu S, Schaffer A, Canadian Network for M, Anxiety Treatments Task F (2012) The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders. Ann Clin Psychiatry 24(1):56–68PubMedGoogle Scholar
  49. Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte BP, Shon SP, Rago WV, Altshuler KZ (2003) Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry 64(4):357–369PubMedCrossRefGoogle Scholar
  50. Rush AJ, Rago WV, Crismon ML, Toprac MG, Shon SP, Suppes T, Miller AL, Trivedi MH, Swann AC, Biggs MM, Shores-Wilson K, Kashner TM, Pigott T, Chiles JA, Gilbert DA, Altshuler KZ (1999) Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. J Clin Psychiatry 60(5):284–291PubMedCrossRefGoogle Scholar
  51. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP (2000) The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med Spec No:1–104Google Scholar
  52. Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, Swinson R, Yatham LN, Canadian Network for M, Anxiety Treatments Task F (2012) The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry 24(1):6–22PubMedGoogle Scholar
  53. Suppes T, Calabrese J, Mitchell P, Pazzaglia P, Potter W, Zarin D (1995) Algorithms for the treatment of bipolar manic-depressive illness. Psychopharmacol Bull 31(3):469–474PubMedGoogle Scholar
  54. Suppes T, Dennehy EB, Swann AC, Bowden CL, Calabrese JR, Hirschfeld RM, Keck PE Jr, Sachs GS, Crismon ML, Toprac MG, Shon SP (2002) Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry 63(4):288–299PubMedCrossRefGoogle Scholar
  55. Suppes T, Rush AJ, Dennehy EB, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Brown ES, Biggs MM, Shores-Wilson K, Witte BP, Trivedi MH, Miller AL, Altshuler KZ, Shon SP (2003) Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry 64(4):370–382PubMedCrossRefGoogle Scholar
  56. Suppes T, Swann AC, Dennehy EB, Habermacher ED, Mason M, Crismon ML, Toprac MG, Rush AJ, Shon SP, Altshuler KZ (2001) Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J Clin Psychiatry 62(6):439–447PubMedCrossRefGoogle Scholar
  57. Yatham LN, Kennedy SH, O’Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP, Canadian Network for M, Anxiety T (2005) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 7(Suppl 3):5–69. doi: 10.1111/j.1399-5618.2005.00219.x PubMedCrossRefGoogle Scholar
  58. Yatham LN, Kennedy SH, O’Donovan C, Parikh SV, MacQueen G, McIntyre RS, Sharma V, Beaulieu S, Guidelines Group C (2006) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord 8(6):721–739. doi: 10.1111/j.1399-5618.2006.00432.x PubMedCrossRefGoogle Scholar
  59. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI (2013a) The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future. Bipolar Disord 15(1):58–60. doi: 10.1111/bdi.12038 PubMedCrossRefGoogle Scholar
  60. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M (2013b) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 15(1):1–44. doi: 10.1111/bdi.12025 PubMedCrossRefGoogle Scholar
  61. Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese JR, Berk M, Ha K, Kapczinski F (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11(3):225–255. doi: 10.1111/j.1399-5618.2009.00672.x, BDI672 [pii]PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Kostas N. Fountoulakis
    • 1
  1. 1.Division of Neurosciences 3rd Department of PsychiatryAristotle University of Thessaloniki School of MedicineThessalonikiGreece

Personalised recommendations